Sage Private Wealth Group LLC Sells 237 Shares of Johnson & Johnson (NYSE:JNJ)
Sage Private Wealth Group LLC Sells 237 Shares of Johnson & Johnson (NYSE:JNJ)
Sage Private Wealth Group LLC cut its holdings in Johnson & Johnson (NYSE:JNJ – Get Rating) by 15.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,340 shares of the company's stock after selling 237 shares during the quarter. Sage Private Wealth Group LLC's holdings in Johnson & Johnson were worth $219,000 as of its most recent SEC filing.
據Sage Private Wealth Group LLC在提交給美國證券交易委員會的最新Form 13F文件中稱,該公司在第三季度減持了15.0%的強生股份。該基金在本季度出售了237股後,持有1,340股該公司股票。截至最近提交的美國證券交易委員會申報文件,思賢私人財富集團持有的強生股份價值21.9萬美元。
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Red Wave Investments LLC raised its holdings in Johnson & Johnson by 2.0% during the 2nd quarter. Red Wave Investments LLC now owns 2,986 shares of the company's stock valued at $530,000 after buying an additional 59 shares during the period. Argus Investors Counsel Inc. raised its holdings in Johnson & Johnson by 0.6% during the 2nd quarter. Argus Investors Counsel Inc. now owns 10,936 shares of the company's stock valued at $1,941,000 after buying an additional 61 shares during the period. Alta Capital Management LLC raised its holdings in Johnson & Johnson by 0.4% during the 2nd quarter. Alta Capital Management LLC now owns 15,824 shares of the company's stock valued at $2,808,000 after buying an additional 61 shares during the period. Paces Ferry Wealth Advisors LLC increased its stake in Johnson & Johnson by 0.7% in the third quarter. Paces Ferry Wealth Advisors LLC now owns 8,724 shares of the company's stock worth $1,425,000 after purchasing an additional 62 shares during the period. Finally, Mason & Associates Inc increased its stake in Johnson & Johnson by 4.9% in the third quarter. Mason & Associates Inc now owns 1,317 shares of the company's stock worth $215,000 after purchasing an additional 62 shares during the period. 67.94% of the stock is owned by institutional investors.
其他一些對衝基金和其他機構投資者最近也買入和賣出了該公司的股票。紅浪投資有限責任公司在第二季度增持了強生2.0%的股份。紅浪投資有限責任公司現在持有該公司2,986股股票,價值53萬美元,在此期間又購買了59股。Argus Investors Counsel Inc.在第二季度將強生的持股比例提高了0.6%。Argus Investors Counsel Inc.在此期間又購買了61股,目前持有10,936股該公司股票,價值1,941,000美元。Alta Capital Management LLC在第二季度增持了強生0.4%的股份。Alta Capital Management LLC現在擁有15,824股該公司的股票,價值2,808,000美元,在此期間又購買了61股。Pes Ferry Wealth Advisors LLC在第三季度增持強生股份0.7%.Pes Ferry Wealth Advisors LLC在此期間又購買了62股,現在擁有8,724股該公司股票,價值1,425,000美元。最後,美盛律師事務所在第三季度增持了強生4.9%的股份。Mason&Associates Inc.在此期間又購買了62股,現在擁有1,317股該公司股票,價值21.5萬美元。67.94%的股份由機構投資者持有。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
A number of research firms have weighed in on JNJ. SVB Leerink reduced their target price on Johnson & Johnson from $194.00 to $186.00 and set an "outperform" rating on the stock in a research note on Friday, January 20th. Barclays began coverage on Johnson & Johnson in a research note on Monday, October 17th. They issued an "equal weight" rating and a $175.00 target price on the stock. Sanford C. Bernstein reduced their target price on Johnson & Johnson from $194.00 to $190.00 in a research note on Wednesday, October 19th. Raymond James cut their price target on Johnson & Johnson from $192.00 to $185.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 19th. Finally, Atlantic Securities raised their price target on Johnson & Johnson from $160.00 to $168.00 and gave the company a "neutral" rating in a research note on Wednesday, January 25th. Seven research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $185.23.
一些研究公司已經加入了對JNJ的看法。1月20日,SVB Leerink在一份研究報告中將強生的目標價從194.00美元下調至186.00美元,並對該股設定了“跑贏大盤”的評級。巴克萊在10月17日星期一的一份研究報告中開始對強生進行報道。他們對該股給予了“同等權重”的評級和175.00美元的目標價。桑福德·伯恩斯坦在10月19日星期三的一份研究報告中將強生的目標價從194.00美元下調至190.00美元。10月19日,雷蒙德·詹姆斯在一份研究報告中將強生的目標價從192.00美元下調至185.00美元,並對該股設定了“跑贏大盤”的評級。最後,大西洋證券將強生的目標價從160.00美元上調至168.00美元,並在1月25日(週三)的一份研究報告中給予該公司“中性”評級。7名研究分析師對該股的評級為持有,6名分析師給出了買入評級,一名分析師給出了該公司股票的強力買入評級。根據MarketBeat.com的數據,該公司的普遍評級為“適度買入”,平均目標價為185.23美元。
Insider Transactions at Johnson & Johnson
強生的內幕交易
Johnson & Johnson Price Performance
強生性價比
Shares of JNJ stock opened at $164.61 on Monday. Johnson & Johnson has a 1-year low of $155.72 and a 1-year high of $186.69. The stock's 50-day moving average is $174.35 and its 200 day moving average is $170.54. The company has a market cap of $430.37 billion, a P/E ratio of 24.42, a PEG ratio of 2.83 and a beta of 0.54. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.43 and a quick ratio of 1.18.
週一,JNJ的股票開盤報164.61美元。強生的一年低點為155.72美元,一年高位為186.69美元。該股的50日移動均線切入位在174.35美元,200日移動均線切入位在170.54美元。該公司市值為4303.7億美元,市盈率為24.42倍,聚乙二醇率為2.83倍,貝塔係數為0.54。該公司的債務權益比為0.37,流動比率為1.43,速動比率為1.18。
Johnson & Johnson (NYSE:JNJ – Get Rating) last issued its quarterly earnings results on Tuesday, January 24th. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.13. The business had revenue of $23.71 billion during the quarter, compared to the consensus estimate of $23.90 billion. Johnson & Johnson had a return on equity of 35.94% and a net margin of 18.90%. The company's quarterly revenue was down 4.4% on a year-over-year basis. During the same quarter last year, the company earned $2.13 earnings per share. Research analysts predict that Johnson & Johnson will post 10.51 earnings per share for the current fiscal year.
強生(紐約證券交易所代碼:JNJ-GET Rating)最近一次發佈季度收益報告是在1月24日,星期二。該公司公佈本季度每股收益為2.35美元,比普遍預期的2.22美元高出0.13美元。該業務本季度營收為237.1億美元,而市場普遍預期為239億美元。強生的股本回報率為35.94%,淨利潤率為18.90%。該公司季度營收同比下降4.4%。去年同期,該公司每股收益為2.13美元。研究分析師預測,強生本財年每股收益將達到10.51歐元。
Johnson & Johnson Announces Dividend
強生宣佈分紅
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 7th. Stockholders of record on Tuesday, February 21st will be paid a $1.13 dividend. This represents a $4.52 annualized dividend and a dividend yield of 2.75%. The ex-dividend date of this dividend is Friday, February 17th. Johnson & Johnson's payout ratio is 67.06%.
該公司最近還披露了季度股息,將於3月7日(星期二)支付。2月21日(星期二)登記在冊的股東將獲得1.13美元的股息。這意味着年化股息為4.52美元,股息收益率為2.75%。本次股息除息日期為2月17日(星期五)。強生的派息率為67.06%.
Johnson & Johnson Profile
強生簡介
(Get Rating)
(獲取評級)
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets.
強生是一家控股公司,從事醫療保健領域產品的研發、製造和銷售。它通過以下細分市場運作:消費者健康、製藥和醫療設備。消費者健康部分包括用於嬰兒護理、口腔護理、美容、非處方藥、婦女健康和傷口護理市場的產品。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- 免費獲取斯托克新聞網關於強生(JNJ)的研究報告
- C3.ai人工智能產品套件是遊戲變革者嗎?
- 市場回顧周-1/30-2/3
- 細價股值得嗎?你應該投資細價股嗎?
- Zimmer Biomet盈利節節攀升,增長可能被計入價格
- 人工智能軟件製造商EPAM號稱科技板塊漲幅最大
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
接受《強生日報》的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對強生及相關公司的最新新聞和分析師評級的每日摘要。